Pens, storage, and missed doses
Can't Find Wegovy Dose at Pharmacy: What to Do Next
The national GLP-1 shortages are over, but a local pharmacy can still run out of one strength. Here are the options to raise with your pharmacist and prescriber, and the records that make each call shorter.
Last reviewed
The Vital angle
Vital keeps your dose history with the date, time, amount, and the lot number and expiration date you saved, so the facts a pharmacist or prescriber asks for are in one place during a supply gap. On iPhone, you can share a PDF of your doses from Settings to send your recent history to a new prescriber or pharmacy.
Why you can't find your Wegovy dose at the pharmacy
If you can't find your Wegovy® dose at a pharmacy, or your Zepbound®, Mounjaro®, or Ozempic® strength is out of stock, you are not alone, even though the national shortages ended. The FDA determined that the tirzepatide injection shortage was resolved in December 2024 and that the semaglutide injection shortage was resolved in February 2025. The FDA's April 2026 update says neither medicine is on its drug shortage list.
The same FDA statement also says patients may still see "intermittent and limited localized supply disruptions" as products move from manufacturers and wholesalers to local pharmacies. In practice, one store can be out of one strength for a week while the next town has it.
First, check the facts
Before you start to call around, confirm what is actually happening:
- Ask the pharmacist whether the dose is out of stock, on back order from the wholesaler, or held up by something else, such as a prior authorization or a refill-too-soon rule.
- Ask when the next delivery is due. Many pharmacies receive orders daily, and a one-day wait is different from a two-week wait.
- Check the FDA Drug Shortages Database for your medicine. If there is a real national shortage, it will show there.
- Count how many days you have until your next dose. That number decides how much time you have to solve the problem.
Options to discuss with your pharmacist
Your pharmacist can do more than say "not in stock." Ask about these options:
- Order it for you. Many pharmacies can place an order with the wholesaler for the next delivery.
- Check other stores. A chain pharmacy can often see stock at nearby locations and move the prescription.
- Transfer the prescription. You can move a prescription to an independent pharmacy, a hospital outpatient pharmacy, or a mail-order pharmacy. Ask the new pharmacy to confirm stock before the transfer.
- Fill a different package of the same dose. Some medicines come in more than one device, such as a single-dose pen, a multi-dose KwikPen®, or a vial. A different device needs a new prescription, and your insurance can treat it differently, so the pharmacist and prescriber both need to agree.
Do not try to build your dose out of smaller pens on your own. Only follow a plan like that if your prescriber writes it and your pharmacist explains it.
Manufacturer pharmacy programs
Both manufacturers now sell through their own pharmacy channels, which gives you another place to look:
- Novocare home delivery (Novo Nordisk) lists the Wegovy pill, Wegovy pen, Ozempic pill, and Ozempic pen. Your prescriber sends the prescription to Novocare, and you then get a confirmation text. A prescription is required.
- LillyDirect (Eli Lilly) offers Zepbound with home delivery, and its Zepbound page lists vials and pickup at Walmart Pharmacy. A prescription from your healthcare provider is required.
These programs focus on self-pay prices. Read the current terms on each site, and ask your insurer whether a self-pay purchase counts toward your deductible, before you ask your prescriber to send a prescription there.
Options to discuss with your prescriber
If the dose you need will not be available before your next shot, call your prescriber. Only the prescriber can decide among options such as these:
- Stay at your current dose for another week or more instead of stepping up.
- Change to a different device or form of the same medicine, such as a vial or the Wegovy tablet.
- Change the pharmacy or the insurance plan route for the prescription.
- Change to a different medicine. This is a bigger decision, and each medicine has its own dose steps. See GLP-1 dosing schedules for how those steps work.
Ask the prescriber to send a new prescription the same day if they choose a change, so the pharmacy can start any prior authorization at once.
Staying on schedule while you wait
A supply gap often turns into a missed dose. Each label has its own missed-dose window, so know yours before the gap starts:
- Ozempic: within 5 days after the missed dose.
- Mounjaro and Zepbound: within 4 days (96 hours) after the missed dose.
- Wegovy injection: if the next dose is less than 2 days away, the label says not to take the missed one.
If the wait is longer than one week, tell your prescriber. The Wegovy label says that after 2 or more missed weeks, the dose escalation restarts at a lower dose to reduce stomach side effects. Ask your prescriber what applies to your medicine. Our missed GLP-1 dose guide gives each label rule in full.
Avoid shortcuts that add risk
When a pharmacy shelf is empty, other offers can look attractive. Be careful with these:
- Online sellers that do not ask for a prescription. A real Wegovy, Ozempic, Mounjaro, or Zepbound product always needs a prescription.
- "Research use" peptides. Products labeled "not for human use" have no medicine-grade checks. See peptide catalog source checks.
- Compounded copies sold as a shortage substitute. Since the shortages ended, the FDA expects compounders to stop making products that are essentially copies of the approved medicines. Compounded drugs are not FDA-approved. Read compounded vs brand semaglutide before you consider one, and talk to your prescriber.
Records that make each call shorter
The same questions come up on every call. Keep these facts in one place:
- The medicine, the exact strength, and the device (pen, KwikPen, vial, or tablet).
- The date and time of your last dose, and the date your next one is due.
- Your prescriber's name and phone number, and the pharmacy that holds the prescription.
- Insurance details and any prior authorization number.
- The lot number and expiration date of your last pen, in case the pharmacist needs to match a product.
- A short log of calls: who you spoke to, the date, and what they said.
With these facts ready, a pharmacist can check stock or a prescriber can send a new prescription in one call.
When to get care now
A gap in supply is not an emergency by itself. Restarting after a gap can bring back nausea, vomiting, or diarrhea, as when you first started. Call your healthcare provider right away if vomiting or diarrhea does not stop, because the labels warn that fluid loss can lead to kidney problems. Get urgent care for severe stomach pain that does not go away, or for signs of a serious allergic reaction, such as swelling of the face, lips, or throat, or trouble breathing.
Wegovy®, Ozempic®, Novocare® are trademarks of Novo Nordisk A/S. Mounjaro®, Zepbound®, KwikPen®, LillyDirect® are trademarks of Eli Lilly and Company. Walmart is a trademark of its respective owner. Vital is independent and not affiliated with these companies.
Things to watch
Practical flags drawn from prescribing information and clinical guidance. Vital surfaces these in the dose log to help you spot them early.
Online sellers that do not ask for a prescription
Every Wegovy, Ozempic, Mounjaro, and Zepbound product requires a prescription. A seller that skips this step is not a legitimate pharmacy.
Peptides labeled for research use
Products sold as not for human use have no medicine-grade quality checks and are not a substitute for a prescribed GLP-1.
Building a dose from smaller pens without a written plan
Combining strengths changes the device, the count of injections, and the insurance claim. Do it only if your prescriber writes the plan and the pharmacist explains it.
Restarting at the full dose after a long gap
The Wegovy label says to restart dose escalation at a lower dose after 2 or more missed weeks to reduce stomach side effects. Ask the prescriber about the restart dose for any brand.
Compounded copies marketed as a shortage substitute
The FDA determined the semaglutide and tirzepatide shortages are resolved, and compounded drugs are not FDA-approved. Talk to your prescriber before you consider one.
Frequently asked questions
No national shortage is listed. The FDA determined the tirzepatide shortage was resolved in December 2024 and the semaglutide shortage in February 2025. The FDA says local pharmacies can still have short, limited supply disruptions.
Local stock depends on wholesaler deliveries, and one strength can run out at one store while others have it. Ask the pharmacist whether it is out of stock, on back order, or held up by a prior authorization, and when the next delivery is due.
Novo Nordisk offers Novocare home delivery for Wegovy and Ozempic, and Eli Lilly offers Zepbound through LillyDirect. Both require a prescription that your prescriber sends to the program.
Call your prescriber before the missed-dose window on your label closes. They can decide whether to keep you at your current dose, change the device or pharmacy, or choose another option.
Only if your prescriber writes that plan and your pharmacist explains it. Do not combine pens on your own.
Compounded drugs are not FDA-approved, and the FDA no longer considers the brand medicines to be in shortage. Talk to your prescriber about the risks before you consider a compounded product.
Sources
- FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize · U.S. Food and Drug Administration
- FDA Drug Shortages Database · U.S. Food and Drug Administration
- Novocare home delivery for GLP-1 medicines · Novo Nordisk
- Zepbound (tirzepatide) through LillyDirect · Eli Lilly and Company
- Wegovy (semaglutide) injection and tablets Prescribing Information · Novo Nordisk
- Zepbound (tirzepatide) Prescribing Information · Eli Lilly and Company
This page summarizes publicly available information from the sources listed above and is for educational use only. It is not medical advice. Consult a qualified healthcare professional for personal dosing guidance.
Track every shot, every change
Vital logs every GLP-1 injection and peptide dose, then surfaces patterns your scale can't show. Free on iOS and Android.
More from the Library
Compounded Semaglutide Storage: Vials, Beyond-Use Dates, and Warning Signs
How to store compounded semaglutide and tirzepatide vials, what a beyond-use date means, and the signs that a vial may be compromised and should not be used.
Ozempic Left Out of the Fridge? Room-Temperature Limits by Brand
Each GLP-1 label gives its own room-temperature limit, and every one says not to use a pen that froze. Here is what the Ozempic, Wegovy, Mounjaro, and Zepbound labels allow, and what to do next.
How to Read Insulin Syringe Units: Tick Marks on 0.3, 0.5, and 1 mL Barrels
How to read insulin syringe units on a U-100 barrel, what each line means on a 30, 50, and 100 unit syringe, how units convert to mL, and the misreads that cause dosing errors.
Peptide Reconstitution Calculator: BAC Water Ratio and Concentration Math
How peptide reconstitution works, how a BAC water ratio sets the concentration in mg per mL, the sterile steps for mixing a vial, and how to store it after mixing.